IPH Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Innate Pharma SA

Watchlist Manager

Watchlist

Price: 1.6 EUR -1.23%

Market Cap: €150.3m

	Innate Pharma SA PAR:IPH	FR
U	Unity Software Inc F:US3	US
P	Pfizer Inc XMUN:PFE	US
F	Fresh Del Monte Produce Inc XMUN:FDM	US
	ACS Actividades de Construccion y Servicios SA MAD:ACS	ES
A	Activision Blizzard Inc F:AIY	US
T	Telefonaktiebolaget LM Ericsson F:ERCB	SE
D	DigitalOcean Holdings Inc XMUN:0SU	US
F	F5 Inc F:FFV	US
E	Energy Vault Holdings Inc F:8610	US
	Qrf NV XBRU:QRF	BE
I	I-Tail PCL Corp SET:ITC	TH
	Infineon Technologies AG F:IFX	DE
	Singapore Airlines Ltd SGX:C6L	SG

Profitability Summary

Innate Pharma SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Strong 3Y Average Gross Margin

67%

Declining Gross Margin

93% > 1%

Negative Operating Margin

-1 834%

Negative 3Y Average Operating Margin

-570%

Declining Operating Margin

-152% > -1 834%

Negative Net Margin

-1 765%

Negative 3Y Average Net Margin

-537%

Declining Net Margin

-144% > -1 765%

Negative Free Cash Flow Margin

-1 898%

Negative 3Y Average Free Cash Flow Margin

-478%

Declining Free Cash Flow Margin

-74% > -1 898%

Exceptional ROE

764%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-221%

Declining ROIC

-55% > -835%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.